StemCells Inc Share Price Nasdaq
Stocks
US85857R3030
Biotechnology & Medical Research
| Market Cap | 12Cr 11Cr 10Cr 9.23Cr 17Cr 1.18TCr 18Cr 117.89Cr 46Cr 591.16Cr 47Cr 46Cr 1.96TCr | P/E 2026 * |
-6.61x | P/E 2027 * | -6.24x |
|---|---|---|---|---|---|
| Enterprise Value | 12Cr 11Cr 10Cr 9.23Cr 17Cr 1.18TCr 18Cr 117.89Cr 46Cr 591.16Cr 47Cr 46Cr 1.96TCr | EV / Sales 2026 * |
36x | EV / Sales 2027 * | 11.7x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: StemCells Inc
| 1 day | -19.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 02/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 01/04/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 21/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CHM | Chairman | 54 | 01/01/2013 |
Scott Burell
BRD | Director/Board Member | 61 | 28/11/2016 |
Martin Madden
BRD | Director/Board Member | 65 | 06/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -19.35% | +575.21% | - | - | 12Cr | |
| +1.05% | -0.28% | +4.25% | +15.99% | 4.86TCr | |
| +1.98% | +9.05% | +413.94% | +532.17% | 4.19TCr | |
| +3.44% | -4.65% | +28.34% | +8.81% | 3.89TCr | |
| +1.40% | +0.10% | +6.61% | +61.93% | 3.72TCr | |
| +2.42% | +5.72% | +12.38% | +44.79% | 3.07TCr | |
| -0.16% | -3.11% | - | - | 1.61TCr | |
| +2.20% | +0.48% | +34.71% | +127.15% | 1.64TCr | |
| +0.72% | +2.30% | +8.64% | +19.52% | 1.4TCr | |
| +4.25% | -8.23% | -1.49% | -35.46% | 1.26TCr | |
| Average | -0.20% | -0.78% | +63.42% | +96.86% | 2.85TCr | |
| Weighted average by Cap. | +1.91% | -0.12% | +83.11% | +120.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.5L 29.88L 27.85L 25.62L 48.36L 33Cr 48.9L 3.27Cr 1.28Cr 16Cr 1.3Cr 1.27Cr 54Cr | 1.06Cr 91.81L 85.58L 78.71L 1.49Cr 100.79Cr 1.5Cr 10Cr 3.95Cr 50Cr 3.98Cr 3.89Cr 167.02Cr |
| Net income | -1.89Cr -1.64Cr -1.53Cr -1.41Cr -2.65Cr -179.99Cr -2.68Cr -18Cr -7.05Cr -90Cr -7.11Cr -6.95Cr -298.26Cr | -2Cr -1.73Cr -1.62Cr -1.49Cr -2.81Cr -190.33Cr -2.84Cr -19Cr -7.45Cr -95Cr -7.52Cr -7.35Cr -315.4Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
